[Distribution of various 57Co-labelled zhengguangmycin preparations in Ehrlich carcinoma bearing mice in relation with their antitumor activity and toxicity (author's transl)].
D000818:Animals; D001761:Bleomycin / Q000009:adverse effects / Q000378:metabolism* / Q000627:therapeutic use / Q000031:analogs & derivatives; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D003037:Cobalt Radioisotopes; D051379:Mice
D003037:Cobalt Radioisotopes; D001761:Bleomycin; C021771:zhengguangmycin